肺动脉高压
重症监护医学
医学
危险分层
临床实习
内科学
物理疗法
作者
Brandon Budhram,Samuel Chung,Marc Humbert,Evelyn M. Horn
标识
DOI:10.1146/annurev-med-042623-013335
摘要
Pulmonary hypertension (PH) is a complex condition characterized by pulmonary vasculopathy and progressive right ventricular dysfunction. Recent advances have reshaped PH management, including refined risk stratification, improved patient phenotyping, and the discovery of novel therapeutics. In alignment with the recommendations of the Seventh World Symposium on Pulmonary Hypertension, we summarize updated treatment strategies and emerging therapies, such as sotatercept, while acknowledging research gaps and areas of clinical equipoise. This practical, evidence-based review explores treatment across all groups of PH to inform clinical decision-making, improve long-term patient outcomes, and address both current and future challenges in PH management.
科研通智能强力驱动
Strongly Powered by AbleSci AI